Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 724 clinical trials
virtualtesting  

Text in a pre element is displayed in a fixed-width font, and it preserves both spaces and line breaks.(*) Coronary heart disease (CHD), cerebrovascular manifestation, peripheral arterial occlusive disease (PAOD) (**) For cardiovascular events (e.g. diabetes mellitus, renal function glomerular filtration rate (GFR) < 60 ml/min) Exclusion Criteria: - Planned …

Accepts healthy volunteers
  • 0 views
  • 30 Aug, 2022
  • 1 location
Demo Study  

Demo Study 

Online studies
  • 0 views
  • 25 Apr, 2025
  • 1 location
Treatment With Romosozumab Versus Denosumab to Improve Bone Mineral Density and Architecture in Subacute SCI  

The objective of the proposed work is to determine whether administration for 12 months of romosozumab followed by 12 months of denosumab will maintain bone mass at the knee in subjects with subacute SCI compared to 24 months of denosumab administration alone.

  • 0 views
  • 14 Mar, 2022
  • 2 locations
Treatment With Romosozumab Versus Denosumab to Improve Bone Mineral Density and Architecture in Subacute SCI  

The objective of the proposed work is to determine whether administration for 12 months of romosozumab followed by 12 months of denosumab will maintain bone mass at the knee in subjects with subacute SCI compared to 24 months of denosumab administration alone.

  • 0 views
  • 14 Mar, 2022
  • 2 locations
Treatment With Romosozumab Versus Denosumab to Improve Bone Mineral Density and Architecture in Subacute SCI test  

The objective of the proposed work is to determine whether administration for 12 months of romosozumab followed by 12 months of denosumab will maintain bone mass at the knee in subjects with subacute SCI compared to 24 months of denosumab administration alone.

Accepts healthy volunteers
  • 0 views
  • 14 Mar, 2022
  • 2 locations
Distal Peripheral Neuropathy in Type 2 Diabetes (DSP/DM)  

Distal sensory peripheral neuropathy (DSP) is a chronic, debilitating painful condition affecting quality of life in persons living with Type 2 diabetes. Treatments prescribed to manage DSP pain, such as nonnarcotic and narcotic analgesics, antidepressants and anticonvulsants, are largely ineffective. This is a preliminary study at assessing the feasibility, efficiency …

  • 0 views
  • 26 Sep, 2022
  • 3 locations
  • 0 views
  • 14 Mar, 2022
  • 1 location
check trial sc rz1  

overview test 12414

Accepts healthy volunteers
  • 0 views
  • 04 Aug, 2023
  • 1 location
oo1  

overview

  • 0 views
  • 05 Aug, 2022
  • 1 location
4.7 MArch  

Test study overview

  • 0 views
  • 04 Apr, 2023
  • 2 locations